Stemline Therapeutics Company
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Employee Number:
11-50
Funding Status:
M&A
Headquarters:
New York, New York, United States
Technology:
Anti-infective Drugs
Estimated Revenue:
$10M to $50M
Founded Date:
2003
Industry:
PharmTech